ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Bayer Launches Baytril Max for Pigs in Europe

16 October 2012, at 2:33pm

EU - Bayer Animal Health has launched Baytril Max for Pigs in Europe to support livestock production and the wellbeing of animals.

Baytril® has been a leading pig antibiotic for nearly 20 years and has just got even better with the launch of Baytril Max for Pigs; a new product to treat bronchopneumonia in pigs. The new Baytril Max for Pigs is available as a single dose concept and is based on a new formulation, which combines high tissue concentrations with good local tolerance. This can reduce the stress of injection and therefore improve the animal's well-being.

Baytril Max for Pigs comes to the UK with a proven heritage in the US and Latin American markets, where it has been successfully used in the treatment of more than six million pigs.

Dr Larry Coleman, a pig vet from Nebraska, USA spoke of the need for the new treatment option: "As we face a future of increasing demand for pork products, the need for fast-acting, effective treatments against common pig respiratory diseases will only increase. The availability of a treatment with proven efficacy and fast onset of action in a single injection will not only reduce stress for treated animals but also decrease the workload for vets and pig farmers."

According to Dr Markus Edingloh, Head of the Marketing Department in Bayer Animal Health UK: "We have seen from other markets the difference that Baytril Max for Pigs brought to veterinary surgeons as well as pig farmers and we are proud to announce that the same product is now available in the UK."

Baytril Max for Pigs reaches peak tissue levels within hours and rapidly reduces the number of susceptible pathogens. It is licensed for the treatment of bacterial bronchopneumonia caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as a secondary pathogen in pigs.

Bayer Animal Health continues to strive for excellence when developing innovative products of proven performance and efficacy whilst supporting their responsible use in animals throughout the world.

For more information on using medicines responsibly, click here.

Further Reading

Find out more information on the diseases mentioned in this article by clicking here.